Novo Nordisk A/S is a prominent global pharmaceutical company based in Bagsværd, Copenhagen, Denmark. Established in 1989 through the merger of two pioneering companies, it has a rich history that dates back to the early 1920s. Novo Nordisk is recognized as the world's largest producer of insulin and a leader in diabetes treatment, focusing on developing, manufacturing, and marketing pharmaceutical products.

The company specializes in diabetes care, offering a wide range of insulin products and other diabetes medications. In addition to diabetes, Novo Nordisk develops therapies for obesity, hemophilia, and growth disorders. The company is committed to research and development, investing significantly in innovative protein-based therapies for chronic diseases. Novo Nordisk's dedication to scientific advancement and humanitarian goals is reflected in its corporate philosophy, which emphasizes improving patient outcomes and social responsibility.